Birchview Capital, LP Karyopharm Therapeutics Inc. Transaction History

Birchview Capital, LP

$95 Million
Q2 2025

A detailed history of Birchview Capital, LP transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Birchview Capital, LP holds 27,985 shares of KPTI stock, worth $177,704. This represents 0.13% of its overall portfolio holdings.

Number of Shares

27,985

Previous 27,985 -0.0%

Holding current value

$177,704

Previous $104,000 15.38%

% of portfolio

0.13%

Previous 0.09%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.6 - $9.83 $235,108 - $3.85 Million	-391,847 Reduced 93.33%	27,985 $104,000
Q4 2024 Jun 30, 2025	SELL	$0.6 - $0.99 $30,000 - $49,500	-50,000 Reduced 10.64%	419,832 $285,000
Q4 2024 Feb 14, 2025	SELL	$0.6 - $0.99 $30,000 - $49,500	-50,000 Reduced 10.64%	419,832 $285,000
Q1 2024 May 14, 2024	SELL	$0.72 - $1.66 $73,440 - $169,320	-102,000 Reduced 17.84%	469,832 $709,000
Q4 2023 Jun 30, 2025	SELL	$0.68 - $1.31 $69,360 - $133,620	-102,000 Reduced 17.84%	469,832 $404,000
Q3 2023 Jun 30, 2025	BUY	$1.14 - $1.81 $619,985 - $984,363	543,847 Added 1943.35%	571,832 $766,000
Q3 2023 Nov 14, 2023	BUY	$1.14 - $1.81 $319,770 - $507,705	280,500 Added 96.28%	571,832 $766,000
Q4 2022 Feb 03, 2023	BUY	$2.48 - $5.93 $54,560 - $130,460	22,000 Added 8.17%	291,332 $991,000
Q1 2022 May 13, 2022	BUY	$5.91 - $14.38 $137,892 - $335,514	23,332 Added 9.48%	269,332 $1.99 Million
Q3 2021 Nov 12, 2021	BUY	$4.45 - $10.63 $71,200 - $170,080	16,000 Added 6.96%	246,000 $1.43 Million
Q1 2021 May 14, 2021	BUY	$9.85 - $17.69 $413,700 - $742,980	42,000 Added 22.34%	230,000 $2.42 Million
Q4 2020 Feb 09, 2021	BUY	$14.15 - $17.19 $283,000 - $343,800	20,000 Added 11.9%	188,000 $2.91 Million
Q2 2020 Aug 10, 2020	BUY	$16.6 - $25.25 $332,000 - $505,000	20,000 Added 13.51%	168,000 $3.18 Million
Q1 2020 May 12, 2020	BUY	$14.38 - $27.72 $977,840 - $1.88 Million	68,000 Added 85.0%	148,000 $2.84 Million
Q4 2019 Feb 12, 2020	BUY	$9.23 - $19.67 $92,300 - $196,700	10,000 Added 14.29%	80,000 $1.53 Million
Q4 2018 Feb 06, 2019	BUY	$8.2 - $16.95 $164,000 - $339,000	20,000 Added 40.0%	70,000 $656,000
Q2 2018 Aug 02, 2018	BUY	$12.0 - $19.88 $600,000 - $994,000	50,000 New	50,000 $850,000

Others Institutions Holding KPTI

# of Institutions

Shares Held

4.38M

Call Options Held

Put Options Held

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $507M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.

Account

Birchview Capital, LP Karyopharm Therapeutics Inc. Transaction History